HomeOwner SearchCategory Search
Diabetes Technology & Therapeutics [Published: 2019-07-08 to 2019-08-30. Issues: vol. 21, no. 7, July 2019 to vol. 21, no. 9, September 2019]
Visit USCO
hero image
Serial Registration
Copyright Title

Diabetes Technology & Therapeutics [Published: 2019-07-08 to 2019-08-30. Issues: vol. 21, no. 7, July 2019 to vol. 21, no. 9, September 2019]

Status

Published

on 31 Oct 2019
Year of Creation
2019
Copyright Claimant
Mary Ann Liebert, Inc
Registration Number
TX0008839967
on 31 Oct 2019

Copyright Summary


The U.S. Copyright record (Registration Number: TX0008839967) dated 31 Oct 2019, pertains to an electronic file (eService) titled "Diabetes Technology & Therapeutics [Published: 2019-07-08 to 2019-08-30. Issues: vol. 21, no. 7, July 2019 to vol. 21, no. 9, September 2019]" created in 2019. The copyright holder is Mary Ann Liebert, Inc, known for their creative contributions in serial registration. For any inquiries concerning this copyrighted material, kindly reach out to Mary Ann Liebert, Inc.

Copyright Details


Copyright Claimant
Mary Ann Liebert, Inc

Application Details


Registration Number
TX0008839967
Registration Date
10/31/2019
Year of Creation
2019
Agency Marc Code
DLC-CO
Record Status
New
Corporate Author
Mary Ann Liebert, Inc
Physical Description
Electronic file (eService)
First Publication Nation
United States
ISSN
1520-9156

Corporate Authors


Notes


Rights Note: Kate Hickey, Mary Ann Liebert Inc., Publishers, 140 Huguenot St, New Rochelle, NY, 10801-5215, (914) 740-2100, khickey@liebertpub.com
Copyright Local Holdings: vol. 21, no. 7, July 2019 Pub. 2019-07-08 Regarding group registration: A group of serial issues may be registered on one application with one filing fee only under limited circumstances. ALL of the following are required: (1) Each issue must be a serial, as defined in 37 C.F.R. 202.4(d); (2) the group must include at least two issues; (3) each issue must be an all-new collective work that has not been previously published; (4) each issue must be fixed and distributed as a discrete, self-contained collective work, and the claim in each issue must be limited to the collective work; (5) each issue must be a work made for hire; (6) the author and claimant for each issue must be the same person or organization; (7) the serial generally must be published at intervals of a week or more; (8) all of the issues must be published under the same continuing title; (9) all of the issues must be published within three months and within the same calendar year; and (10) the applicant must specify the date of publication for each issue in the group Reg. 2019-11-01 TX0008839967 AHSAvol. 21, no. 8, August 2019 Pub. 2019-08-01 Regarding group registration: A group of serial issues may be registered on one application with one filing fee only under limited circumstances. ALL of the following are required: (1) Each issue must be a serial, as defined in 37 C.F.R. 202.4(d); (2) the group must include at least two issues; (3) each issue must be an all-new collective work that has not been previously published; (4) each issue must be fixed and distributed as a discrete, self-contained collective work, and the claim in each issue must be limited to the collective work; (5) each issue must be a work made for hire; (6) the author and claimant for each issue must be the same person or organization; (7) the serial generally must be published at intervals of a week or more; (8) all of the issues must be published under the same continuing title; (9) all of the issues must be published within three months and within the same calendar year; and (10) the applicant must specify the date of publication for each issue in the group Reg. 2019-11-01 TX0008839967 AHSAvol. 21, no. 9, September 2019 Pub. 2019-08-30 Regarding group registration: A group of serial issues may be registered on one application with one filing fee only under limited circumstances. ALL of the following are required: (1) Each issue must be a serial, as defined in 37 C.F.R. 202.4(d); (2) the group must include at least two issues; (3) each issue must be an all-new collective work that has not been previously published; (4) each issue must be fixed and distributed as a discrete, self-contained collective work, and the claim in each issue must be limited to the collective work; (5) each issue must be a work made for hire; (6) the author and claimant for each issue must be the same person or organization; (7) the serial generally must be published at intervals of a week or more; (8) all of the issues must be published under the same continuing title; (9) all of the issues must be published within three months and within the same calendar year; and (10) the applicant must specify the date of publication for each issue in the group Reg. 2019-11-01 TX0008839967 AHSA
Local Copyright Note: Regarding group registration: A group of serial issues may be registered on one application with one filing fee only under limited circumstances. ALL of the following are required: (1) Each issue must be a serial, as defined in 37 C.F.R. 202.4(d); (2) the group must include at least two issues; (3) each issue must be an all-new collective work that has not been previously published; (4) each issue must be fixed and distributed as a discrete, self-contained collective work, and the claim in each issue must be limited to the collective work; (5) each issue must be a work made for hire; (6) the author and claimant for each issue must be the same person or organization; (7) the serial generally must be published at intervals of a week or more; (8) all of the issues must be published under the same continuing title; (9) all of the issues must be published within three months and within the same calendar year; and (10) the applicant must specify the date of publication for each issue in the group

Statements


Application Title Statement: Diabetes Technology & Therapeutics
Author Statement: Mary Ann Liebert, Inc employer for hire Authorship: collective work
Get your copyright registered todayThousands have copyrighted their assets.
What are you waiting for?

© 2024 reserved by Trademarkia
Show terms & conditions